Universal Technical Institute Inc’s filing revealed that its Director Coliseum Capital Management, L unloaded Company’s shares for reported $17.5 million on May 27 ’25. In the deal valued at $35.00 per share,500,000 shares were sold. As a result of this transaction, Coliseum Capital Management, L now holds 2,716,267 shares worth roughly $90.29 million.
Then, Hitchcock Todd A sold 27,500 shares, generating $917,471 in total proceeds. Upon selling the shares at $33.36, the EVP/COO now owns 80,521 shares.
Before that, Brochick George W. sold 6,000 shares. Universal Technical Institute Inc shares valued at $191,040 were divested by the Director at a price of $31.84 per share. As a result of the transaction, Brochick George W. now holds 32,516 shares, worth roughly $1.08 million.
A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Northland Capital began covering UTI with “an Outperform” recommendation on January 10, 2024. Argus revised its rating on June 23, 2023. It rated UTI as “a Hold” which previously was an “a Buy”.
Price Performance Review of UTI
On Monday, Universal Technical Institute Inc [NYSE:UTI] saw its stock fall -6.00% to $33.24. Over the last five days, the stock has lost -7.41%. Universal Technical Institute Inc shares have risen nearly 29.29% since the year began. Nevertheless, the stocks have risen 116.97% over the past one year. While a 52-week high of $36.32 was reached on 05/22/25, a 52-week low of $13.66 was recorded on 04/07/25. SMA at 50 days reached $30.56, while 200 days put it at $24.47.
Levels Of Support And Resistance For UTI Stock
The 24-hour chart illustrates a support level at 31.82, which if violated will result in even more drops to 30.39. On the upside, there is a resistance level at 35.04. A further resistance level may holdings at 36.83. The Relative Strength Index (RSI) on the 14-day chart is 48.57, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.67, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 74.58%. Stochastics %K at 47.15% indicates the stock is a holding.
The most recent change occurred on July 12, 2022 when Rosenblatt began covering the stock and recommended ‘”a Buy”‘ rating along with a $11 price target.
